Sarepta Therapeutics (Commercial Rights to DMD Drug) Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • Asset Purch.

  • Financing Rounds

  • 1

Sarepta Therapeutics (Commercial Rights to DMD Drug) General Information

Description

Rights to a drug for treating duchenne muscular dystrophy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Roche
Primary Office
  • 215 First Street
  • Cambridge, MA 02142
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sarepta Therapeutics (Commercial Rights to DMD Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sarepta Therapeutics (Commercial Rights to DMD Drug)‘s full profile, request access.

Request a free trial

Sarepta Therapeutics (Commercial Rights to DMD Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sarepta Therapeutics (Commercial Rights to DMD Drug)‘s full profile, request access.

Request a free trial